Lena Winstedt

1.3k total citations
17 papers, 657 citations indexed

About

Lena Winstedt is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Lena Winstedt has authored 17 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Oncology. Recurrent topics in Lena Winstedt's work include Bacterial Genetics and Biotechnology (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Photosynthetic Processes and Mechanisms (3 papers). Lena Winstedt is often cited by papers focused on Bacterial Genetics and Biotechnology (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Photosynthetic Processes and Mechanisms (3 papers). Lena Winstedt collaborates with scholars based in Sweden, Denmark and United States. Lena Winstedt's co-authors include Claes von Wachenfeldt, Christian Kjellman, Sofia Järnum, Yasutaro Fujita, Ken‐ichi Yoshida, Lars Hederstedt, Anna Runström, Robert Bockermann, Lars Björck and Tomas Lorant and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Bacteriology.

In The Last Decade

Lena Winstedt

17 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lena Winstedt Sweden 13 279 152 131 112 79 17 657
David M. Coder United States 13 276 1.0× 62 0.4× 86 0.7× 192 1.7× 79 1.0× 24 742
M Nowaczyk Poland 11 156 0.6× 33 0.2× 30 0.2× 114 1.0× 44 0.6× 56 539
Felix Bohne Germany 12 253 0.9× 81 0.5× 223 1.7× 257 2.3× 223 2.8× 18 1.0k
Laurie Sower United States 13 340 1.2× 91 0.6× 8 0.1× 186 1.7× 40 0.5× 19 782
Julia Tait Lathrop United States 12 636 2.3× 46 0.3× 14 0.1× 91 0.8× 28 0.4× 17 910
Jooho Chung United States 14 322 1.2× 60 0.4× 23 0.2× 299 2.7× 78 1.0× 23 857
Jia Shi China 13 153 0.5× 68 0.4× 13 0.1× 237 2.1× 29 0.4× 25 557
Jarkko Räbinä Finland 15 536 1.9× 84 0.6× 7 0.1× 123 1.1× 103 1.3× 27 778
Dalil Hannani France 18 321 1.2× 40 0.3× 16 0.1× 604 5.4× 41 0.5× 37 1.0k

Countries citing papers authored by Lena Winstedt

Since Specialization
Citations

This map shows the geographic impact of Lena Winstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Winstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Winstedt more than expected).

Fields of papers citing papers by Lena Winstedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lena Winstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Winstedt. The network helps show where Lena Winstedt may publish in the future.

Co-authorship network of co-authors of Lena Winstedt

This figure shows the co-authorship network connecting the top 25 collaborators of Lena Winstedt. A scholar is included among the top collaborators of Lena Winstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena Winstedt. Lena Winstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Potter, Rachael A., S A Khan, Jenna Snedeker, et al.. (2023). P17 Safety and efficacy of pre-treatment with imlifidase prior to AAV-based gene therapy in non-human primates with pre-existing anti-AAVrh74 antibodies. Neuromuscular Disorders. 33. S101–S101. 1 indexed citations
2.
Bockermann, Robert, Sofia Järnum, Anna Runström, et al.. (2021). Imlifidase-generated Single-cleaved IgG: Implications for Transplantation. Transplantation. 106(7). 1485–1496. 12 indexed citations
3.
Jordan, Stanley C., Christophe Legendre, Niraj M. Desai, et al.. (2020). Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes). Transplantation. 105(8). 1808–1817. 66 indexed citations
4.
Lorant, Tomas, Mats Bengtsson, Torsten Eich, et al.. (2018). Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients. American Journal of Transplantation. 18(11). 2752–2762. 70 indexed citations
5.
Karlsson, Christofer, Sofia Järnum, Lena Winstedt, et al.. (2018). Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS. Molecular & Cellular Proteomics. 17(6). 1097–1111. 16 indexed citations
6.
Järnum, Sofia, Anna Runström, Robert Bockermann, et al.. (2017). Enzymatic Inactivation of Endogenous IgG by IdeS Enhances Therapeutic Antibody Efficacy. Molecular Cancer Therapeutics. 16(9). 1887–1897. 9 indexed citations
7.
Wang, Yuzhong, Ming Hu, Weifang Wang, et al.. (2017). IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome. Experimental Neurology. 291. 134–140. 18 indexed citations
8.
Winstedt, Lena, Sofia Järnum, Emma Andersson Nordahl, et al.. (2015). Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS – A Novel Therapeutic Opportunity. PLoS ONE. 10(7). e0132011–e0132011. 81 indexed citations
9.
Järnum, Sofia, Robert Bockermann, Anna Runström, Lena Winstedt, & Christian Kjellman. (2015). The Bacterial Enzyme IdeS Cleaves the IgG-Type of B Cell Receptor (BCR), Abolishes BCR-Mediated Cell Signaling, and Inhibits Memory B Cell Activation. The Journal of Immunology. 195(12). 5592–5601. 39 indexed citations
10.
Lassen, Ulrik, Dorte Nielsen, Morten Mau‐Sørensen, et al.. (2012). A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours. British Journal of Cancer. 106(4). 678–684. 37 indexed citations
11.
12.
Riisbro, Rikke, Lena Winstedt, Steve Pakola, et al.. (2009). Abstract A3: A first-in-man, phase I, dose escalation study of TB-403, a monoclonal antibody directed against PlGF, in healthy male subjects. Molecular Cancer Therapeutics. 8(12_Supplement). A3–A3. 1 indexed citations
13.
Lassen, Ulrik, Dorte Nielsen, Morten Mau‐Sørensen, et al.. (2009). Abstract A111: A phase I, dose escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with solid tumors. Molecular Cancer Therapeutics. 8(12_Supplement). A111–A111. 3 indexed citations
14.
Bengtsson, Jenny, Claes von Wachenfeldt, Lena Winstedt, Per Nygaard, & Lars Hederstedt. (2004). CtaG is required for formation of active cytochrome c oxidase in Bacillus subtilis. Microbiology. 150(2). 415–425. 23 indexed citations
15.
Winstedt, Lena & Claes von Wachenfeldt. (2000). Terminal Oxidases of Bacillus subtilis Strain 168: One Quinol Oxidase, Cytochrome aa 3 or Cytochrome bd , Is Required for Aerobic Growth. Journal of Bacteriology. 182(23). 6557–6564. 76 indexed citations
16.
Winstedt, Lena, et al.. (2000). Enterococcus faecalis V583 Contains a Cytochrome bd -Type Respiratory Oxidase. Journal of Bacteriology. 182(13). 3863–3866. 74 indexed citations
17.
Winstedt, Lena, Ken‐ichi Yoshida, Yasutaro Fujita, & Claes von Wachenfeldt. (1998). Cytochrome bd Biosynthesis in Bacillus subtilis : Characterization of the cydABCD Operon. Journal of Bacteriology. 180(24). 6571–6580. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David M. Coder Breakdown of academic impact, for papers by M Nowaczyk Breakdown of academic impact, for papers by Felix Bohne Breakdown of academic impact, for papers by Laurie Sower Breakdown of academic impact, for papers by Julia Tait Lathrop Breakdown of academic impact, for papers by Jooho Chung Breakdown of academic impact, for papers by Jia Shi Breakdown of academic impact, for papers by Jarkko Räbinä Breakdown of academic impact, for papers by Dalil Hannani
Rankless by CCL
2026